- 全部删除
- 您的购物车当前为空
INHBE (Inhibin Subunit Beta E) is a Protein Coding gene. This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate an inhibin beta subunit. INHBE was identified as a novel putative hepatokine with hepatic gene expression that positively correlated with insulin resistance and body mass index in humans. The quantitative real time-PCR analysis also showed an increase in INHBE gene expression in independent liver samples from insulin-resistant human subjects. INHBE functions as a possible hepatokine to alter the whole-body metabolic status under obese insulin-resistant conditions. Diseases associated with INHBE include Brachydactyly, Type A2, and Liver Benign Neoplasm.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μg | ¥ 3,430 | 5日内发货 |
生物活性 | Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
产品描述 | INHBE (Inhibin Subunit Beta E) is a Protein Coding gene. This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate an inhibin beta subunit. INHBE was identified as a novel putative hepatokine with hepatic gene expression that positively correlated with insulin resistance and body mass index in humans. The quantitative real time-PCR analysis also showed an increase in INHBE gene expression in independent liver samples from insulin-resistant human subjects. INHBE functions as a possible hepatokine to alter the whole-body metabolic status under obese insulin-resistant conditions. Diseases associated with INHBE include Brachydactyly, Type A2, and Liver Benign Neoplasm. |
种属 | Human |
表达系统 | HEK293 Cells |
标签 | N-hFc |
蛋白编号 | P58166 |
别名 | inhibin β E,inhibin beta E |
蛋白构建 | A DNA sequence encoding the human INHBE (NP_113667.1) (Thr237-Ser350) was expressed with the Fc region of human IgG1 at the N-terminus. Predicted N terminal: Glu |
蛋白纯度 | > 90 % as determined by SDS-PAGE. |
分子量 | 40.9 kDa (predicted) |
内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
缓冲液 | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
复溶方法 | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
存储 | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
运输方式 | In general, Lyophilized powders are shipping with blue ice. |
研究背景 | INHBE (Inhibin Subunit Beta E) is a Protein Coding gene. This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate an inhibin beta subunit. INHBE was identified as a novel putative hepatokine with hepatic gene expression that positively correlated with insulin resistance and body mass index in humans. The quantitative real time-PCR analysis also showed an increase in INHBE gene expression in independent liver samples from insulin-resistant human subjects. INHBE functions as a possible hepatokine to alter the whole-body metabolic status under obese insulin-resistant conditions. Diseases associated with INHBE include Brachydactyly, Type A2, and Liver Benign Neoplasm. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.